360 related articles for article (PubMed ID: 23290791)
21. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
[TBL] [Abstract][Full Text] [Related]
22. Risperidone adjunctive therapy duration in the maintenance treatment of bipolar I disorder: A post hoc analysis.
Valdes M; Bertolin S; Qian H; Wong H; Lam RW; Yatham LN
J Affect Disord; 2019 Mar; 246():861-866. PubMed ID: 30795492
[TBL] [Abstract][Full Text] [Related]
23. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
Sachs G; Sanchez R; Marcus R; Stock E; McQuade R; Carson W; Abou-Gharbia N; Impellizzeri C; Kaplita S; Rollin L; Iwamoto T;
J Psychopharmacol; 2006 Jul; 20(4):536-46. PubMed ID: 16401666
[TBL] [Abstract][Full Text] [Related]
24. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
[TBL] [Abstract][Full Text] [Related]
25. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
[TBL] [Abstract][Full Text] [Related]
26. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ
Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520
[TBL] [Abstract][Full Text] [Related]
27. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392).
Carlson BX; Ketter TA; Sun W; Timko K; McQuade RD; Sanchez R; Vester-Blokland E; Marcus R
Bipolar Disord; 2012 Feb; 14(1):41-53. PubMed ID: 22329471
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.
Roy Chengappa KN; Schwarzman LK; Hulihan JF; Xiang J; Rosenthal NR;
J Clin Psychiatry; 2006 Nov; 67(11):1698-706. PubMed ID: 17196048
[TBL] [Abstract][Full Text] [Related]
29. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.
Calabrese JR; Shelton MD; Rapport DJ; Youngstrom EA; Jackson K; Bilali S; Ganocy SJ; Findling RL
Am J Psychiatry; 2005 Nov; 162(11):2152-61. PubMed ID: 16263857
[TBL] [Abstract][Full Text] [Related]
30. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.
Keck PE; Marcus R; Tourkodimitris S; Ali M; Liebeskind A; Saha A; Ingenito G;
Am J Psychiatry; 2003 Sep; 160(9):1651-8. PubMed ID: 12944341
[TBL] [Abstract][Full Text] [Related]
31. The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole.
Missio G; Moreno DH; Fernandes F; Bio DS; Soeiro-de-Souza MG; Rodrigues dos Santos D; David DP; Costa LF; Demétrio FN; Moreno RA
Trials; 2013 Jun; 14():190. PubMed ID: 23805994
[TBL] [Abstract][Full Text] [Related]
32. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.
Calabrese JR; Pikalov A; Streicher C; Cucchiaro J; Mao Y; Loebel A
Eur Neuropsychopharmacol; 2017 Sep; 27(9):865-876. PubMed ID: 28689688
[TBL] [Abstract][Full Text] [Related]
33. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
34. Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
McIntyre RS
Clin Ther; 2010; 32 Suppl 1():S32-8. PubMed ID: 20152551
[TBL] [Abstract][Full Text] [Related]
35. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
Maina G; Albert U; Salvi V; Mancini M; Bogetto F
J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
[TBL] [Abstract][Full Text] [Related]
36. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
[TBL] [Abstract][Full Text] [Related]
37. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
J Affect Disord; 2015 Oct; 185():31-7. PubMed ID: 26143402
[TBL] [Abstract][Full Text] [Related]
38. Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.
Tohen M; Sutton VK; Calabrese JR; Sachs GS; Bowden CL
J Affect Disord; 2009 Jul; 116(1-2):43-50. PubMed ID: 19054570
[TBL] [Abstract][Full Text] [Related]
39. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
Loebel A; Cucchiaro J; Silva R; Kroger H; Sarma K; Xu J; Calabrese JR
Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
